好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2015 Annual Meeting | 7MS.002 - The Interface Between Infection and Cerebrovascular Disease

Friday 04/24/15
06:30 AM - 08:00 AM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Morning Seminar
Mitchell S. Elkind, MD, MS, FAAN
Global Health and Neuroepidemiology
Participants should become familiar with the risk of stroke in patients with acute or chronic infections; learn how to prevent strokes and other cerebrovascular diseases in patients with acute or chronic infections; and be able to overcome the challenge of balancing the benefits of HIV-control strategies against the potential risk of stroke associated with these interventions.
1.50 CME credits
Patient Care & Procedural Skills
Trainee, General Neurologist, Specialist Neurologist, Advanced Practice Provider
Case-based, Didactic, Interactive
Event Timeline
06:30 AM - 06:35 AM Introduction: Infection and Stroke
Mitchell S. Elkind, MD, MS, FAAN
06:35 AM - 07:00 AM Cerebrovascular Disease in HIV/AIDS
Reza Behrouz, DO, PhD, FAAN
07:00 AM - 07:25 AM Bacterial Endocarditis and Cerebrovascular Disease
Scott L. Silliman, MD
07:25 AM - 07:50 AM Infectious Cerebral Vasculitides
Sebastian Koch, MD
07:50 AM - 08:00 AM Questions and Answers
Faculty Disclosures
Mitchell S. Elkind, MD, MS, FAAN Dr. Elkind has received personal compensation for serving as an employee of American Heart Association. Dr. Elkind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Atria Academy.
Reza Behrouz, DO, PhD, FAAN No disclosure on file
Scott L. Silliman, MD Dr. Silliman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech.
Sebastian Koch, MD Dr. Koch has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Multiple Legal Matters. Dr. Koch has received stock or an ownership interest from Cerepeutics. Dr. Koch has received intellectual property interests from a discovery or technology relating to health care. Dr. Koch has received intellectual property interests from a discovery or technology relating to health care.